Sanara MedTech Inc. (SMTI) News
Filter SMTI News Items
SMTI News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest SMTI News From Around the Web
Below are the latest news stories about SANARA MEDTECH INC that investors may wish to consider to help them evaluate SMTI as an investment opportunity.
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4thFORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company’s Chairman and Chief Executive Officer, will present at the |
Sanara MedTech Inc. (NASDAQ:SMTI) Just Reported Earnings, And Analysts Cut Their Target PriceSanara MedTech Inc. ( NASDAQ:SMTI ) just released its latest quarterly results and things are looking bullish. Results... |
Sanara MedTech Third Quarter 2024 Earnings: Beats ExpectationsSanara MedTech ( NASDAQ:SMTI ) Third Quarter 2024 Results Key Financial Results Revenue: US$21.7m (up 35% from 3Q... |
Sanara MedTech Inc (SMTI) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...Sanara MedTech Inc (SMTI) achieves its 12th consecutive record revenue quarter, while navigating increased expenses and strategic expansions. |
Sanara MedTech Inc. Reports Third Quarter 2024 ResultsFORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its strategic, operational and financial results for the quarter ended September 30, 202 |
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownershipKey Insights Sanara MedTech's significant insider ownership suggests inherent interests in company's expansion A total... |
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call DatesFORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara |
Sanara MedTech Inc. Announces Changes to Its Board of DirectorsFORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from hi |
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five yearsSanara MedTech Inc. ( NASDAQ:SMTI ) shareholders have seen the share price descend 12% over the month. But in stark... |
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLCFORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara’s joint venture partner InfuSystem Holdings, Inc., announced today the execution of an |